Addex Therapeutics Stock Performance
| ADXN Stock | USD 8.62 0.16 1.82% |
The firm shows a Beta (market volatility) of 1.0, which signifies a somewhat significant risk relative to the market. Addex Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Addex Therapeutics is expected to follow. At this point, Addex Therapeutics has a negative expected return of -0.24%. Please make sure to confirm Addex Therapeutics' maximum drawdown, and the relationship between the information ratio and expected short fall , to decide if Addex Therapeutics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Addex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return 2.33 | Five Day Return 9.75 | Year To Date Return 39.37 | Ten Year Return (39.45) | All Time Return (39.45) |
Last Split Factor 1:20 | Last Split Date 2023-10-23 |
1 | Why Addex Therapeutics stock skyrocketed 70 percent on Tuesday - MSN | 09/09/2024 |
2 | Addex Therapeutics Reports Strong Mid-Year Growth - TipRanks | 09/30/2024 |
3 | What Makes Addex Therapeutics a New Buy Stock | 10/04/2024 |
4 | Akebia Therapeutics Reports Q3 Loss, Misses Revenue Estimates | 11/07/2024 |
5 | Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update - Marketscreener.com | 11/21/2024 |
| Begin Period Cash Flow | 7 M |
Addex |
Addex Therapeutics Relative Risk vs. Return Landscape
If you would invest 1,086 in Addex Therapeutics on August 30, 2024 and sell it today you would lose (224.00) from holding Addex Therapeutics or give up 20.63% of portfolio value over 90 days. Addex Therapeutics is currently does not generate positive expected returns and assumes 5.1134% risk (volatility on return distribution) over the 90 days horizon. In different words, 45% of stocks are less volatile than Addex, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Addex Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Addex Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Addex Therapeutics, and traders can use it to determine the average amount a Addex Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.046
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ADXN |
Estimated Market Risk
| 5.11 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Addex Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Addex Therapeutics by adding Addex Therapeutics to a well-diversified portfolio.
Addex Therapeutics Fundamentals Growth
Addex Stock prices reflect investors' perceptions of the future prospects and financial health of Addex Therapeutics, and Addex Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Addex Stock performance.
| Return On Equity | -1.26 | ||||
| Return On Asset | -0.62 | ||||
| Profit Margin | 5.00 % | ||||
| Operating Margin | (7.80) % | ||||
| Current Valuation | 4.93 M | ||||
| Shares Outstanding | 1.07 M | ||||
| Price To Book | 0.75 X | ||||
| Price To Sales | 10.87 X | ||||
| Revenue | 1.61 M | ||||
| Gross Profit | 1.44 M | ||||
| EBITDA | (10.23 M) | ||||
| Net Income | (10.56 M) | ||||
| Cash And Equivalents | 8.81 M | ||||
| Cash Per Share | 1.40 X | ||||
| Total Debt | 344.34 K | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 2.55 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (7.99 M) | ||||
| Earnings Per Share | (21.60) X | ||||
| Market Capitalization | 9.38 M | ||||
| Total Asset | 4.64 M | ||||
| Retained Earnings | (360.42 M) | ||||
| Working Capital | 1.34 M | ||||
| Current Asset | 32.02 M | ||||
| Current Liabilities | 4.82 M | ||||
About Addex Therapeutics Performance
By examining Addex Therapeutics' fundamental ratios, stakeholders can obtain critical insights into Addex Therapeutics' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Addex Therapeutics is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.27) | (2.16) | |
| Return On Capital Employed | (5.90) | (5.60) | |
| Return On Assets | (2.27) | (2.16) | |
| Return On Equity | (9.22) | (8.75) |
Things to note about Addex Therapeutics performance evaluation
Checking the ongoing alerts about Addex Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Addex Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Addex Therapeutics generated a negative expected return over the last 90 days | |
| Addex Therapeutics has high historical volatility and very poor performance | |
| Addex Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.61 M. Net Loss for the year was (10.56 M) with profit before overhead, payroll, taxes, and interest of 1.44 M. | |
| Addex Therapeutics currently holds about 8.81 M in cash with (7.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.4. | |
| Addex Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update - Marketscreener.com |
- Analyzing Addex Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Addex Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Addex Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Addex Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Addex Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Addex Therapeutics' stock. These opinions can provide insight into Addex Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (21.60) | Revenue Per Share 1.2 | Quarterly Revenue Growth (0.82) | Return On Assets (0.62) | Return On Equity (1.26) |
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.